MTOR and type 2 diabetes mellitus: While PTDM shares common risk factors with type 2 diabetes mellitus (T2DM), such as central obesity, age, inflammation, genetic susceptibility, PTDM-specific risk factors including the use of glucocorticoids, calcineurin inhibitors (CNIs) and mTOR inhibitors also play a role (Jenssen and Hartmann 2019).